| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e13cf25eb1bef6199475314477618b46 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate |
2010-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_763ba6b59f6f290fb3a4d9c88305c2f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f7ea2d5cad5dad0f25f1fcbd65b3123
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8d80345cb383a1d77e0715f12ae9f80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_895db185f0f8c77dfeeb5dfde486b6bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28c7bf414433c574c19c442793332e8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fe4bbc74df157c503ae11bc4529de85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6341d2bb06db07cfc39bda0e7edb141
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8304b27278937b66afa9180fe7d5fc7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b13b6533ca6448a9603193b268ca927 |
| publicationDate |
2011-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2010218853-A1 |
| titleOfInvention |
Tricyclic pyrazolopyrimidine derivative |
| abstract |
Disclosed is a novel compound which inhibits an activity of HSP90, in particular a novel compound which inhibits a function of HSP90 as a chaperone protein and has an antitumor activity. Specifically disclosed are: a pyrazolopyrimidine compound represented by formula (1) having various substituents, which inhibits an ATPase activity of HSP90 and has an antitumor activity; an HSP90 inhibitor which contains a compound represented by formula (1); a pharmaceutical formulation which contains a compound represented by formula (1); an antitumor agent which contains a compound represented by formula (1); a pharmaceutical composition which contains a compound represented by formula (1); and a method for treating a cancer, wherein a compound represented by formula (1) is used. |
| priorityDate |
2009-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |